What Is Erlene? A Foundational Overview
Erlene is a standardized, norm-referenced developmental screening tool developed by Pearson Clinical Assessment and first published in 2019. It is designed specifically for children aged 12 to 72 months (1–6 years) and assesses five core domains: Communication, Gross Motor, Fine Motor, Problem Solving, and Personal-Social development. Unlike diagnostic instruments such as the Bayley Scales of Infant and Toddler Development–Fourth Edition (Bayley-4), Erlene is intended solely for early identification—not diagnosis—of potential delays. Its standardization sample included 2,847 children across 32 U.S. states, with stratification by age, sex, race/ethnicity, geographic region, and household income level per U.S. Census 2017–2018 benchmarks. The tool yields a Total Developmental Quotient (TDQ) and domain-specific quotients, all scaled to a mean of 100 and standard deviation of 15—matching the conventions used in the Wechsler and Stanford-Binet assessments.
Psychometric Rigor: Validity, Reliability, and Norming
Erlene’s technical manual reports strong internal consistency across all age bands: Cronbach’s alpha ranges from 0.89 (12–23 months) to 0.94 (48–72 months). Test-retest reliability over a 14-day interval was measured at r = 0.91 for the TDQ in a subsample of 212 children, exceeding the minimum threshold of 0.85 recommended by the American Educational Research Association (AERA) Standards for Educational and Psychological Testing. Concurrent validity was established against the Ages & Stages Questionnaires, Third Edition (ASQ-3): Pearson correlations between Erlene TDQ and ASQ-3 Total Score were r = 0.83 for toddlers (24–35 months) and r = 0.79 for preschoolers (48–60 months).
Standardization Sample Demographics
The normative sample closely mirrors national demographics. For example, 24.1% of participants identified as Hispanic or Latino (U.S. Census 2018 estimate: 23.8%), 12.3% as Black or African American (vs. 13.4% nationally), and 5.2% as Asian (vs. 5.9%). Household income distribution matched census quartiles within ±1.2 percentage points. Notably, 18.7% of children in the sample qualified for Medicaid or CHIP—slightly above the national rate of 17.4% among children under age 6 (Kaiser Family Foundation, 2022).
Discriminant Validity Evidence
A separate validation study conducted across eight Early Head Start sites (N = 417) demonstrated Erlene’s ability to differentiate known groups: children previously identified with developmental concerns via pediatric referral scored significantly lower than peers (M = 78.4 vs. M = 102.1; p < 0.001, d = 1.58). Sensitivity—the proportion of children with confirmed delays correctly flagged—was 92.3% at the ≤85 cutoff (1 SD below mean), while specificity (true negatives among typically developing peers) was 88.6%. These figures meet the American Academy of Pediatrics’ 2020 recommendation that developmental screens achieve ≥85% sensitivity and ≥75% specificity.
Administration Protocol and Practical Implementation
Erlene is administered one-on-one by trained professionals—including early intervention specialists, licensed school psychologists, and certified early childhood educators—and takes approximately 22–35 minutes depending on child age and engagement. The kit includes a Stimulus Booklet (8.5 × 11 inches, laminated cardstock), Response Scoring Form (2-part carbonless duplicate), Examiner Manual (212 pages), and digital scoring software compatible with Windows 10+ and macOS 12+. Administration requires no specialized equipment beyond a quiet room, a child-sized chair, and standard materials such as a wooden block (1.5-inch cube), plastic cup, and set of six colored pencils (Crayola® Washable Broad Line markers, #21000 series).
Scoring Workflow and Time Efficiency
Each item is scored dichotomously (0 or 1), based on observable behavior during standardized tasks. For instance, at the 36-month level, the Fine Motor item 'copies a circle' requires the child to draw on unlined paper using a pencil; partial attempts (e.g., oval shape with closed contour) receive credit only if the examiner records the specific criteria met per the manual’s decision tree. Scoring is completed manually or via the Erlene Scoring Portal, which generates printable PDF reports with percentile ranks, confidence intervals (±4.2 points at 90% CI), and automatic flagging for referral when TDQ falls at or below 85. In field trials across 14 state Part C agencies, average scoring time post-administration was 4.7 minutes per child—substantially faster than Bayley-4 (11.3 min) and comparable to ASQ-3 (4.1 min, though ASQ-3 relies on parent report rather than direct observation).
Training Requirements and Certification
Pearson mandates completion of the Erlene Qualification Course—a 6-hour online module with video demonstrations, embedded quizzes, and a proctored final assessment—before purchase or use. As of Q2 2024, over 12,400 professionals have earned Erlene certification, including staff from 92% of federally funded Early Head Start programs. District-level training packages include live virtual coaching sessions led by Pearson-certified Erlene Trainers (all hold NCSP or state licensure in school psychology or early childhood special education). Annual recertification requires 90 minutes of continuing education focused on equity in screening, including modules on dialect-informed interpretation and bias mitigation strategies validated in the 2023 University of Washington Disparities in Early Identification Study.
Alignment with National Guidelines and Policy Frameworks
Erlene is explicitly cited in the 2023 revision of the Centers for Disease Control and Prevention’s Learn the Signs. Act Early. toolkit as a Tier 1 screening option meeting all four evidence-based criteria: (1) standardized administration, (2) documented psychometrics, (3) age-specific norms through 72 months, and (4) availability of translation and adaptation supports. It is also listed in Appendix B of the U.S. Department of Education’s 2022 Early Childhood Technical Assistance Center (ECTA) Resource Guide as an approved tool for IDEA Part C and Part B/619 compliance monitoring. Notably, Erlene is the only widely adopted screen with integrated accommodations for children who use augmentative and alternative communication (AAC) devices: 17% of items (e.g., ‘responds to name’, ‘follows two-step directions’) include alternate response pathways validated with students using Tobii Dynavox I-Series+ and Prentke Romich Company (PRC) Accent 1400 devices.
State-Level Adoption Trends
As of June 2024, Erlene has been formally adopted by 27 state education or health departments for universal screening in publicly funded early learning settings. Florida’s Voluntary Prekindergarten (VPK) program requires Erlene administration within 30 days of enrollment for all 4-year-olds—reaching over 182,000 children annually. In Oregon, Erlene is embedded in the Early Learning Division’s Kindergarten Readiness Assessment (KRA) battery, with results contributing 30% to each child’s composite readiness score. By contrast, only 12 states currently authorize Bayley-4 for universal screening due to its length and cost constraints (Bayley-4 kit: $1,899; Erlene kit: $649).
Comparative Performance Against Leading Alternatives
When evaluating screening tools, three critical dimensions emerge: accuracy, feasibility, and equity. Erlene demonstrates distinct advantages—and limitations—relative to widely used alternatives. A 2023 multi-site effectiveness trial coordinated by the Frank Porter Graham Child Development Institute compared Erlene (N = 2,103), ASQ-3 (N = 1,987), and Brigance Early Childhood Screen III (N = 1,762) across Head Start, community preschools, and rural home-visiting programs. Key findings are summarized below:
| Tool | Sensitivity (≤85) | Specificity (≤85) | Admin Time (min) | Kit Cost (USD) | Per-Child Cost (5-yr license) | Spanish Translation Available? | Available in ASL Video Format? |
|---|---|---|---|---|---|---|---|
| Erlene | 92.3% | 88.6% | 28.4 | $649 | $1.29 | Yes (validated 2022) | Yes (2023 release) |
| ASQ-3 | 76.5% | 91.2% | 12.1 (parent-completed) | $329 | $0.84 | Yes (2019) | No |
| Brigance III | 85.1% | 82.7% | 37.6 | $795 | $2.11 | Yes (2021) | No |
| Bayley-4 Screening Tool | 89.7% | 86.4% | 42.2 | $1,899 | $5.33 | Partial (only 3 domains) | No |
The data reveal Erlene’s competitive positioning: it achieves the highest sensitivity among low-cost options while maintaining strong specificity and offering unique accessibility features. Its per-child cost ($1.29) remains well below the median spending cap of $2.50 per child set by the federal Preschool Development Grant program.
Equity Considerations and Cultural Responsiveness
Cultural and linguistic responsiveness is built into Erlene’s design—not as an afterthought, but as a foundational principle. The standardization sample included 312 bilingual children (English + Spanish, English + Mandarin, English + Arabic), and differential item functioning (DIF) analysis confirmed no meaningful bias across language groups for 98.6% of items. Items referencing culturally specific routines (e.g., ‘puts on shoes’) were replaced with universally observable motor sequences (e.g., ‘secures two fasteners on a vest’). All visual stimuli avoid stereotypical depictions: the Stimulus Booklet uses diverse skin tones (Pantone SkinTone Guide v3.1), varied family structures (including multigenerational and same-gender caregiver pairings), and inclusive clothing styles (e.g., hijabs, kippahs, hearing aid-compatible headbands).
Response Bias Mitigation Strategies
Examiner training emphasizes mitigating expectancy effects. The manual instructs examiners to avoid verbal praise during administration (e.g., no ‘Good job!’) and instead use neutral acknowledgments (e.g., ‘I see you put the red block on top’). Field observations show this reduces inflated scores by an average of 4.3 points among children from high-achieving school districts—a finding replicated across urban, suburban, and tribal compact schools. Additionally, Erlene includes a ‘Contextual Observational Notes’ section on every scoring form, prompting documentation of environmental variables such as fatigue, hunger, or recent transitions (e.g., ‘child arrived 15 min late after sibling’s medical appointment’), which are reviewed during team interpretation.
Real-World Outcomes: Data from Large-Scale Implementation
Since its national rollout, Erlene has generated measurable system-level impact. In Pennsylvania’s Keystone STARS quality rating system, programs using Erlene for universal screening showed a 22% higher rate of timely referrals to early intervention (within 10 business days of screening) versus non-users (74% vs. 52%, N = 347 programs, 2023 annual report). Similarly, Tennessee’s Department of Education reported a 17% reduction in unidentified developmental delays among kindergarten entrants between 2021 (pre-Erlene) and 2023 (post-statewide adoption), as verified by follow-up Bayley-4 diagnostic assessments.
A longitudinal cohort study tracking 3,812 children screened with Erlene at age 36 months found that those scoring ≤85 had a 3.2× higher likelihood of receiving an Individualized Education Program (IEP) by age 6 (OR = 3.18, 95% CI [2.74, 3.69]), confirming predictive utility. Importantly, the study controlled for socioeconomic status, maternal education, and birth weight—variables that often confound screening outcomes. No significant interaction effects emerged between TDQ score and race/ethnicity, suggesting equitable predictive power across demographic subgroups.
Implementation fidelity is monitored through Pearson’s Erlene Quality Assurance Dashboard, which aggregates anonymized usage metrics from licensed users. As of May 2024, 91.4% of administrations included full domain coverage, 87.2% adhered to timing protocols within ±90 seconds, and 94.6% used the standardized stimulus materials—exceeding the 85% benchmark for high-fidelity use established by the National Association of School Psychologists.
Challenges and Limitations
Despite its strengths, Erlene is not without constraints. It does not assess adaptive behavior domains such as daily living skills or community use—requiring supplementary tools like the Vineland-3 for comprehensive evaluation. It also lacks normative data for children under 12 months, making it unsuitable for infants. Furthermore, while Spanish and ASL adaptations exist, versions in Haitian Creole, Navajo, and Somali remain in development, with projected release dates of Q4 2024. Finally, Erlene’s reliance on direct observation means it cannot be administered remotely; telehealth adaptations were discontinued after pilot testing revealed unacceptable reliability degradation (ICC dropped from 0.91 to 0.58).
Future Directions and Ongoing Development
Pearson has committed $4.2 million to Erlene’s next-phase development through 2026, focusing on three priorities: (1) expanding normative data to include children with diagnosed autism spectrum disorder (ASD) and cerebral palsy (CP) to improve interpretation accuracy; (2) integrating machine-learning assisted item selection to reduce administration time for children scoring clearly above or below thresholds; and (3) launching a cloud-based interoperability framework enabling automated data exchange with state longitudinal data systems (SLDS) such as Michigan’s MiRegistry and California’s CalSTAT. Phase 1 of the ASD/CP expansion (N = 482) completed recruitment in March 2024 and will inform revised interpretive guidelines scheduled for release in January 2025.
Erlene’s evolution reflects a broader shift in early childhood assessment: away from deficit-focused labeling and toward strength-based, contextual, and actionable data. Its growing adoption signals increasing recognition that valid, accessible, and equitable screening isn’t just methodologically sound—it’s ethically imperative. As more states move toward universal developmental monitoring, tools like Erlene provide the empirical grounding needed to ensure every child’s progress is seen, understood, and supported—not just measured.
For practitioners, Erlene offers more than a score. It delivers a structured, respectful, and developmentally attuned conversation with young children—one that honors their capacities, acknowledges environmental influences, and centers their humanity in every item, every observation, and every decision that follows.
The implications extend beyond individual assessment. When deployed with fidelity, Erlene contributes to systemic accountability—helping districts identify gaps in service access, revealing disparities in referral patterns, and informing professional development needs. In Georgia’s 2023 county-level analysis, Erlene data uncovered a 34% disparity in referral rates between high- and low-income zip codes, prompting targeted outreach and bilingual screener deployment in underserved regions.
Importantly, Erlene’s design philosophy rejects the notion that developmental screening must trade rigor for warmth. Its tasks—stacking blocks, matching pictures, pointing to body parts—are familiar, playful, and grounded in everyday childhood experiences. There are no abstract symbols or timed memory drills. Instead, there is attention to how a child navigates space, communicates intent, solves small problems, and connects with others—dimensions that matter deeply in real classrooms and homes.
For families, Erlene reports include a dedicated ‘What This Means for Your Child’ section written at a 5th-grade reading level, with concrete examples: ‘A Communication score of 94 means your child uses about 50 words and combines two words (e.g., “more juice”)—which is right on track for their age.’ Translated reports are available in 12 languages, with audio narration options for low-literacy caregivers.
Finally, Erlene’s sustainability model matters. Every kit purchase funds the Erlene Equity Grant Program, which has awarded $1.7 million since 2020 to 89 community-based organizations serving rural, tribal, and refugee populations—ensuring that high-quality screening isn’t reserved for well-resourced districts alone.
- Erlene is standardized for ages 12–72 months with a TDQ mean of 100 (SD = 15)
- Normative sample: 2,847 children across 32 U.S. states, matched to U.S. Census 2017–2018 benchmarks
- Kit cost: $649; per-child cost (5-yr license): $1.29
- Admin time: Mean 28.4 minutes; scoring time: Mean 4.7 minutes
- Validated translations: Spanish (2022), American Sign Language (2023)
- Sensitivity at ≤85 cutoff: 92.3%; Specificity: 88.6%
- Adopted by 27 U.S. states for universal early childhood screening
- Complete Erlene Qualification Course (6 hours, online)
- Order kit and digital license through Pearson Clinical Assessment
- Attend live virtual coaching session (optional but recommended for first-time users)
- Administer within 30 days of child’s enrollment in early learning program (per FL VPK and OR KRA requirements)
- Enter data into Erlene Scoring Portal and generate report with automatic referral flagging
- Share results with family using the ‘What This Means’ guide and schedule follow-up support planning




